Eliminating Delays to Clinical Studies
Situation / Issue
BAP Pharma received an urgent request from a new client in October 2021, for an order of medical devices. These needed to be sourced from a specific supplier for use in an ongoing clinical study.
After initial communications with the supplier, BAP Pharma understood that the medical devices were manufactured to order only.
With a large backlog of orders due to the global coronavirus pandemic, our client was facing a 12-to-16-week lead time, which was going to negatively impact their ongoing study and cause significant expense.